Sreoshi Chatterjee 452 posts 0 comments

Unum Therapeutics  which is a clinical-stage bio pharmaceutical company focused on the development of novel immunotherapy products designed to utilize the power of  patient's immune…
Read More...

Cardiovascular Systems, Inc which is a medical device company curating and developing breakthrough interventional treatment systems for patients with peripheral and coronary artery…
Read More...

Biogen and Abbvie asserted voluntary worldwide withdrawal of ZINBRYTA for relapsing multiple sclerosis. Taking into account the limited number of patients who are being treated,…
Read More...

The Biotechnology Organization and MichBio support Governor Rick Snyder for signing critical legislation to pave way for the substitution of Interchangeable biologic medicines conveying…
Read More...

CSA medical declared the completion of the treatment phase for its ongoing study The Safety and Feasibility Study of RejuvenAir for Treating Chronic Bronchitis Patients (NCT02483637).…
Read More...

JHL Biotech has asserted that the Dutch Healthcare Authority has sanctioned a Clinical Trial Application for JHL's dornase alfa biosimilar, JHL1922 to enhance pulmonary function of…
Read More...

Ionis Pharmaceuticals which is a leader in antisense therapeutics asserted that the positive top-line data from a completed Phase 1/2 study of IONIS-HTTRx      in people with early…
Read More...

Ageless Forever asserts to offer GAINSWave which is an innovative noninvasive medical therapy that utilizes low-intensity shockwave therapy to treat Erectile Dysfunction symptoms. It…
Read More...

Regeneron Pharmaceuticals and Sanofi claimed that the U.S Food and Drug Administration has considered to assess the supplemental Biologics License Application (sBLA) of DUPIXENT as an…
Read More...

Mylan set to introduce two new HIV treatments namely, Symfi Lo and Cimduo that was sanctioned in February by the U.S Food and Drug Administration. Introducing Symfi Lo in the coming…
Read More...